How comprehensively 3D ultrasound could be used in a cervical cancer patient to visualize internal organs and position of the device used to hold radioactive source during brachytherapy (internal radiation therapy)?
Not Applicable
Completed
- Conditions
- Health Condition 1: null- Cervical cancer patients (age 18 years)prescribed treatment with HDR brachytherapy (intra-cavitary)
- Registration Number
- CTRI/2015/06/005840
- Lead Sponsor
- Philips India Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 30
Inclusion Criteria
Having been prescribed treatment with radiation therapy including HDR brachytherapy (intra-cavitary
Exclusion Criteria
•Stage less than 1 A
•Patients who have underwent hysterectomy
•Consent not available
•Recurrent cases of tumor
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To assess the feasibility of visualizing applicator, tumor and relevant organs (uterus, cervix, parametrium, bladder and rectum, sigmoid, etc.) in patients with cervical cancer with intracavitary HDR brachytherapy in 3D ultrasound images using a trans-abdominal probe.Timepoint: 2 Months
- Secondary Outcome Measures
Name Time Method â?¢Find a potential systematic scan protocol for acquiring the 3D volumes that will match the MRI data listed in the GEC-ESTROTimepoint: Two months